PG17 Asthma phenotyping

Postgraduate Course
Chairs: A. Spanevello (Milan, Italy), I. Adcock (London, United Kingdom)
Aims: Access educational materials here
to present the innovations in asthma stratification that facilitate personalised therapeutic strategies; to highlight the importance of stratifying asthma patients for selecting the correct therapeutic approaches; to explain the importance of both clinical and biomarker assessment in patient stratification; and to indicate the value of molecular stratification for understanding disease-driving mechanisms and how this may translate to new therapies, particularly for non-Type 2 (T2) asthma.
The need for asthma phenotyping
S. Saglani (London, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Biomarker-high patients and steroid responsiveness
P. Gibson (Newcastle, Australia)
WebcastSlide presentation
WebcastSlide presentation
Group assignment
S. Saglani (London, United Kingdom), P. Gibson (Newcastle, Australia)
WebcastWebcastSlide presentationSlide presentation
WebcastWebcastSlide presentationSlide presentation
Unbiased approaches to asthma stratification - the road to novel therapies
P. Sterk (Amsterdam, Netherlands)
WebcastSlide presentation
WebcastSlide presentation
Patient stratification and targeted drug therapy - T2 asthma and beyond
P. Nair (Hamilton (ON), Canada)
WebcastSlide presentation
WebcastSlide presentation
Group assignment
P. Sterk (Amsterdam, Netherlands), P. Nair (Hamilton (ON), Canada)
No content made available
No content made available